COMMUNIQUÉS West-GlobeNewswire

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
16/03/2026
BRISBANE, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that [...]
Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock
16/03/2026
CRANFORD, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“ Enzon ” or the “ Company ”) today announced that it has extended the expiration date for the exchange offer by the Company [...]
CMR Surgical Advances Physical AI to Support the Future of Robotic Surgery with NVIDIA
16/03/2026
Cambridge-based surgical robotics company contributes majority of surgical data to world’s largest open healthcare robotics dataset Cambridge, UK and San Jose, California – 16 March 2026, CMR Surgical (“CMR”), the [...]
Roche launches NVIDIA AI factory to accelerate the development of new therapeutics and diagnostics solutions
16/03/2026
With the addition of 2,176 NVIDIA Blackwell GPUs, Roche now operates the pharmaceutical industry’s largest announced hybrid-cloud AI factory, totaling more than 3,500 GPUs. The new computational infrastructure supports [...]
Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
16/03/2026
Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody drug conjugate (ADC) targeting CD46, in metastatic castration-resistant prostate cancer (mCRPC) is actively enrolling and remains on track for [...]
CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
16/03/2026
SOUTH SAN FRANCISCO, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a leader in the field of masked, conditionally activated biologics, today announced that it has commenced an [...]
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
16/03/2026
Clinical update on track for Q2 2026 for Phase 2 trial of silevertinib in patients with non-classical EGFRm NSCLC, including preliminary DOR and PFS data in frontline setting Company is preparing to initiate a [...]
LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC
16/03/2026
Company to Report Fourth Quarter Financial Results and Provide Strategic Update on March 31, 2026 ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global [...]
Tobias Burkhardt’s Paretofit Reports 98.1% Success Rate Across 169 Entrepreneur Coaching Engagements
16/03/2026
Paretofit, founded by Tobias Burkhardt, reports a 98.1% documented success rate across 169 completed coaching engagements with entrepreneurs, founders, and self-employed professionals in the DACH region. Köln, NORDRHEIN [...]
Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026
16/03/2026
Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026 IRVINE, California – March 16, 2026 ( [...]
Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial
16/03/2026
-- Four substudies did not meet pre-specified primary endpoints -- -- Post hoc analyses show setmelanotide achieved statistically significant BMI reductions in patients with obesity due to a heterozygous variant of the [...]
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
16/03/2026
RADNOR, Pa., March 16, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic [...]
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
16/03/2026
Southlake, Texas, March 16, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing [...]
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
16/03/2026
Advanced research and development of CUE-401 for IND (Investigational New Drug) readiness – CUE-401 is the Company’s lead asset for the treatment of autoimmune and inflammatory diseases Appointed industry veteran [...]
Annual General Meeting in ALK-Abelló A/S held on 16 March 2026
16/03/2026
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B): ALK-Abelló A/S held its Annual General Meeting on 16 March 2026. The Annual General Meeting transacted the following business: Approval of the annual report 2025 and discharge [...]
IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference
16/03/2026
ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 38 th Annual Roth Conference. Iradimed’s CEO, Roger Susi, and CFO, Jack Glenn, will [...]
Novonesis issues EUR 1.7 billion in bonds to refinance bridge facility
16/03/2026
COPENHAGEN, Denmark – March 16, 2026 . Novonesis has completed a EUR 1.7 billion bond issuance, with significant interest from a broad group of investors. The transaction was primarily undertaken to refinance the bridge [...]
A Race Against Blindness Announces Spring 2026 Luxury Vehicle Fundraiser in Partnership with Foundation Fighting Blindness to Advance Pediatric Inherited Retinal Disease Research
16/03/2026
SCOTTSDALE, Ariz., March 16, 2026 (GLOBE NEWSWIRE) -- A Race Against Blindness (RAB) today announced the launch of its Spring 2026 national fundraiser, Two Winners, One Drive for Vision Research , in strategic [...]
Amlogenyx Announces Positive Preclinical Data on AM805, a Potent Amyloid-Degrading Protease for the Treatment of Alzheimer’s Disease
16/03/2026
Novel and potent catalytic approach that directly clears amyloid on the inside of neurons as well as reduces amyloid plaques with the potential to be superior to monoclonal antibodies and restore neuronal function while [...]

Pages